Word

NANO ENABLED MACHINE LEARNING

Status

Dead

Status Code

602

Status Date

Saturday, June 20, 2020

Serial Number

88314102

Mark Type

4000

Filing Date

Monday, February 25, 2019

Abandoned Date

Tuesday, June 2, 2020

Trademark Owner History

Essenlix Corporation

Classifications

1 Assays for research purposes; Biological and chemical reagents used for non-medical research and laboratory purposes, in vitro and in vivo scientific use, the testing of bodily fluids, and the detecting and analyzing of cells, proteins, small molecules, and nucleotides; Biological and chemical test kits comprised of biological, chemical, or diagnostic reagents for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, for laboratory and research use

5 Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cells, proteins, small molecules, nucleotides, and nucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic biomarker reagents for medical purposes; Biological and chemical test kits for personal wellness in the nature of diagnostic test kits consisting primarily of medical diagnostic reagents and assays for testing of bodily fluids and substances extracted from bodily fluids, namely, cells, proteins, small molecules, nucleotides, and nucleic acids for use in disease detection, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases

10 Medical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, and nucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, medical apparatus for diagnostic testing of health conditions, diseases, or abnormalities, namely, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical apparatus, devices, and instruments for wellness testing, health condition testing, and healthcare testing, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical apparatus, devices, and instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, in the nature of apparatus for DNA and RNA testing for medical purposes

42 Scientific laboratory services, namely, detection and identification of cells, proteins, small molecules, and nucleotides in a sample for scientific, research, and technological purposes; Medical laboratory services, namely, providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of infectious and residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; Development of new technology for others in the fields of biotechnology, DNA, RNA, small molecules, proteins, and nucleotide analysis services for scientific research purposes; Providing medical and scientific research information in the field of clinical trials, assays and assay development, diagnostics, cancer, RNA, DNA, small molecules, proteins, and nucleotides; Research and development in the medical and digital diagnostics and biotechnology fields; Custom design and development of chemical reagents and biochemical assays; Laboratory research in the field of oncology, hematology, and infectious diseases

44 Medical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Healthcare services, namely, the diagnosis of diseases, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic services, namely, medical testing for diagnostic purposes; Wellness services, namely, providing wellness information in the fields of health and wellness; Medical services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample in the nature of medical testing for diagnostic or treatment purposes

Trademark Events

Jun 22, 2020

Abandonment Notice E-Mailed - Failure To Respond

Jun 20, 2020

Abandonment - Failure To Respond Or Late Response

Dec 1, 2019

Notification Of Final Refusal Emailed

Dec 1, 2019

Final Refusal E-Mailed

Dec 1, 2019

Final Refusal Written

Nov 7, 2019

Teas/Email Correspondence Entered

Nov 6, 2019

Correspondence Received In Law Office

Nov 6, 2019

Teas Response To Office Action Received

May 8, 2019

Notification Of Non-Final Action E-Mailed

May 8, 2019

Non-Final Action E-Mailed

May 8, 2019

Non-Final Action Written

May 6, 2019

Assigned To Examiner

Mar 15, 2019

New Application Office Supplied Data Entered In Tram

Feb 28, 2019

New Application Entered In Tram